GL1X · GenesisL1 explorer

Research workbench

Structure of human ULK4 in complex with an inhibitor

Analyse Structure of human ULK4 in complex with an inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6U5L
Type
protein
Length
276 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein kinase ULK4
EC
2.7.11.1
UniProt
Q96C45
Ligands
3RJ
Pockets
2 · best druggability 0.66

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASERINE/THREONINE-protein kinase ULK4 (EC 2.7.11.1)protein27641% helix, 17% strandQ96C45

Ligands and binding sites

  • 3RJ · N~2~-(1H-benzimidazol-6-yl)-N~4~-(5-cyclobutyl-1H-pyrazol-3-yl)quinazoline-2,4-diamine · ligand · chains A
  • GOL · Glycerol · additive · 4 copies · chains A
  • PEG · Di(hydroxyethyl)ether · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13520.660.80353RJ
21800.500.7724empty

Compared structures

  • 6U5L · Structure of human ULK4 in complex with an inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • Q96C45 · AlphaFold monomer V2.0 prediction for SERINE/THREONINE-protein kinase ULK4 (Q96C45) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.